These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25736687)

  • 1. CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy.
    Escamilla J; Schokrpur S; Liu C; Priceman SJ; Moughon D; Jiang Z; Pouliot F; Magyar C; Sung JL; Xu J; Deng G; West BL; Bollag G; Fradet Y; Lacombe L; Jung ME; Huang J; Wu L
    Cancer Res; 2015 Mar; 75(6):950-62. PubMed ID: 25736687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer.
    Xu J; Escamilla J; Mok S; David J; Priceman S; West B; Bollag G; McBride W; Wu L
    Cancer Res; 2013 May; 73(9):2782-94. PubMed ID: 23418320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal Network between Cancer Stem-Like Cells and Macrophages Facilitates the Progression and Androgen Deprivation Therapy Resistance of Prostate Cancer.
    Huang H; Wang C; Liu F; Li HZ; Peng G; Gao X; Dong KQ; Wang HR; Kong DP; Qu M; Dai LH; Wang KJ; Zhou Z; Yang J; Yang ZY; Cheng YQ; Tian QQ; Liu D; Xu CL; Xu DF; Cui XG; Sun YH
    Clin Cancer Res; 2018 Sep; 24(18):4612-4626. PubMed ID: 29691294
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients.
    Teixeira AL; Ribeiro R; Cardoso D; Pinto D; Lobo F; Fraga A; Pina F; Calais-da-Silva F; Medeiros R
    Clin Cancer Res; 2008 Jun; 14(11):3367-71. PubMed ID: 18519765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer.
    Nonomura N; Takayama H; Nakayama M; Nakai Y; Kawashima A; Mukai M; Nagahara A; Aozasa K; Tsujimura A
    BJU Int; 2011 Jun; 107(12):1918-22. PubMed ID: 21044246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer.
    Guan W; Hu J; Yang L; Tan P; Tang Z; West BL; Bollag G; Xu H; Wu L
    Endocr Relat Cancer; 2019 Jan; 26(1):131-140. PubMed ID: 30400004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.
    Neubert NJ; Schmittnaegel M; Bordry N; Nassiri S; Wald N; Martignier C; Tillé L; Homicsko K; Damsky W; Maby-El Hajjami H; Klaman I; Danenberg E; Ioannidou K; Kandalaft L; Coukos G; Hoves S; Ries CH; Fuertes Marraco SA; Foukas PG; De Palma M; Speiser DE
    Sci Transl Med; 2018 Apr; 10(436):. PubMed ID: 29643229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-colony stimulating factor (CSF1) predicts breast cancer progression and mortality.
    Richardsen E; Uglehus RD; Johnsen SH; Busund LT
    Anticancer Res; 2015 Feb; 35(2):865-74. PubMed ID: 25667468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors.
    Kumar V; Donthireddy L; Marvel D; Condamine T; Wang F; Lavilla-Alonso S; Hashimoto A; Vonteddu P; Behera R; Goins MA; Mulligan C; Nam B; Hockstein N; Denstman F; Shakamuri S; Speicher DW; Weeraratna AT; Chao T; Vonderheide RH; Languino LR; Ordentlich P; Liu Q; Xu X; Lo A; Puré E; Zhang C; Loboda A; Sepulveda MA; Snyder LA; Gabrilovich DI
    Cancer Cell; 2017 Nov; 32(5):654-668.e5. PubMed ID: 29136508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.
    Cannarile MA; Weisser M; Jacob W; Jegg AM; Ries CH; Rüttinger D
    J Immunother Cancer; 2017 Jul; 5(1):53. PubMed ID: 28716061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF1/CSF1R Axis Blockade Limits Mesothelioma and Enhances Efficiency of Anti-PDL1 Immunotherapy.
    Magkouta SF; Vaitsi PC; Pappas AG; Iliopoulou M; Kosti CN; Psarra K; Kalomenidis IT
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34067348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment.
    Maldonado MDM; Schlom J; Hamilton DH
    Cancer Immunol Immunother; 2023 Oct; 72(10):3349-3362. PubMed ID: 37505292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug insight: role of the androgen receptor in the development and progression of prostate cancer.
    Taplin ME
    Nat Clin Pract Oncol; 2007 Apr; 4(4):236-44. PubMed ID: 17392714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses.
    Mitchem JB; Brennan DJ; Knolhoff BL; Belt BA; Zhu Y; Sanford DE; Belaygorod L; Carpenter D; Collins L; Piwnica-Worms D; Hewitt S; Udupi GM; Gallagher WM; Wegner C; West BL; Wang-Gillam A; Goedegebuure P; Linehan DC; DeNardo DG
    Cancer Res; 2013 Feb; 73(3):1128-41. PubMed ID: 23221383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapeutic strategies for castration resistant prostate cancer: inhibition of persistent androgen production and androgen receptor mediated signaling.
    Molina A; Belldegrun A
    J Urol; 2011 Mar; 185(3):787-94. PubMed ID: 21239012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-nitrosylation of CSF1 receptor increases the efficacy of CSF1R blockage against prostate cancer.
    Firdaus F; Kuchakulla M; Qureshi R; Dulce RA; Soni Y; Van Booven DJ; Shah K; Masterson T; Rosete OJ; Punnen S; Hare JM; Ramasamy R; Arora H
    Cell Death Dis; 2022 Oct; 13(10):859. PubMed ID: 36209194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroendocrine differentiation in adenocarcinoma of prostate during combined androgen blockade therapy: a case report].
    Kitamoto K; Hayashi T; Tamada S; Ezaki K; Kawashima H; Sugimura K; Nakatani T
    Hinyokika Kiyo; 2005 Jan; 51(1):33-5. PubMed ID: 15732339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of colony stimulating factor 1 and macrophage migration inhibitory factor expression by inflammatory cytokines in term human decidua: implications for macrophage trafficking at the fetal-maternal interface.
    Arcuri F; Buchwalder L; Toti P; Cintorino M; Tosi P; Lockwood CJ; Rybalov B; Schatz F
    Biol Reprod; 2007 Mar; 76(3):433-9. PubMed ID: 17108334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-Targeting by CSF1/1R Blockade in Pancreatic Cancers.
    Ho WJ; Jaffee EM
    Cancer Res; 2021 Dec; 81(24):6071-6073. PubMed ID: 34911778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.
    Palmberg C; Koivisto P; Kakkola L; Tammela TL; Kallioniemi OP; Visakorpi T
    J Urol; 2000 Dec; 164(6):1992-5. PubMed ID: 11061898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.